Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
< Previous
1
2
Next >
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
February 21, 2025
Tags
Health care industry
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
February 20, 2025
Tags
LILLY DRN
Science
Biotech and Pharmaceuticals
From
CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
Tags
LILLY DRN
Health care industry
Science
From
CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
Tags
Health care industry
Science
CVS Health Corp
From
CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
February 13, 2025
Tags
Bosch Ltd
US Economy
World Economy
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 06, 2025
Tags
Technology
Earnings
Alphabet Inc
From
CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags
Health care industry
Earnings
LILLY DRN
From
CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
February 05, 2025
Tags
Earnings
Breaking News: Europe
LILLY DRN
From
CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
February 04, 2025
Tags
Social issues
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
5 things to know before the stock market opens Monday
February 03, 2025
Tags
Bristol/Myers Squibb Co
Palantir Technologies Inc
Politics
From
CNBC.com News
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
February 02, 2025
Tags
Merck & Co Inc
Pfizer Inc
Technology
From
CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
January 31, 2025
Tags
Advanced Micro Devices Inc
PepsiCo Inc/
U/S/ Markets
From
CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
January 28, 2025
Tags
LILLY DRN
Science
Business
From
CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
January 28, 2025
Tags
Social issues
Elevance Health Inc
Medicare
From
CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
January 26, 2025
Tags
Health & Science
Business News
US: News
From
CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
January 21, 2025
Tags
World economy
Pharmaceuticals
Davos WEF
From
CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
January 18, 2025
Tags
IQVIA Holdings Inc
AI / Artificial Intelligence
Health & Science
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Amgen Inc
Bristol/Myers Squibb Co
Pfizer Inc
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Biotech and Pharmaceuticals
Bristol/Myers Squibb Co
Eisai Co Ltd
From
CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
January 14, 2025
Tags
Stock markets
LILLY DRN
JPMorgan Chase & Co
From
CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags
UnitedHealth Group Inc
Bristol/Myers Squibb Co
Pfizer Inc
From
CNBC.com News
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
January 14, 2025
Tags
LILLY DRN
Earnings
Business
From
CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
January 13, 2025
Tags
LILLY DRN
Business
Health care industry
From
CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
January 10, 2025
Tags
Health & Science
Novo Nordisk A/S
Labor economy
From
CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags
Health care industry
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags
Iovance Biotherapeutics Inc
LILLY DRN
Accolade Inc
From
CNBC.com News
Cramer's Lightning Round: Uber is a buy
January 02, 2025
Tags
Business
AES Corp
Investment Strategy
From
CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
Health care costs
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.